Red List

INBXInhibrx Biosciences, Inc.

Healthcare · Biotechnology · small-cap ($1.4B)
-45.9%
from rolling 252-day high of $155.29 set 2026-04-22 · 90d ago
Current
$85.72
Decline depth
-45.9%
Decline σ
6.2σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since tracking began

$INBX has been tracked since 2026-03-01. It was down 18.1% from its 52-week high then — now down -45.9%.

It has clawed back 10.7 percentage points off that level. It bottomed 38.3% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-02 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

INBX qualifies for the Red List on decline depth.

Decline depth
-45.9%
From rolling 252-day high of $155.29, 90d ago. Past the 40% Red List threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
6.2σ
Drop from local high over the last 10 bars, expressed in units of the stock's typical daily volatility (3.48% per day). Past the ≥6σ Amber threshold.

The structural read

What price action says about INBX.

INBX qualifies for the Red List on decline depth — down -45.9% from its rolling 252-day high. Past the 40% threshold, the deepest tier in the taxonomy. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 6.2σ over 10 bars.

Earnings on file: 2026-05-14. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $13.92 50.8% of range 52W high $155.29

Sector context · Healthcare

148 other Healthcare tickers are on Broken Stocks.

69 Red List
40 Amber
39 Watch
-34.5% Median decline

Worst in sector: KRRO (-79.4%). Least-bad: ATR (-20.0%). See all Healthcare listings →

Questions about INBX

What people ask.

Why is INBX on Broken Stocks?

INBX qualifies for the Red List on decline depth. It is down -45.9% from its rolling 252-day high of $155.29, set on 2026-04-22 — 90d ago.

Is INBX a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. INBX is down -45.9% from its 52-week high of $155.29, set 90d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is INBX a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is INBX trading inside its 52-week range?

At $85.72, INBX sits 50.8% of the way from its 52-week low ($13.92) to its 52-week high ($155.29). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has INBX been declining?

The current 45.9% decline accrued over 90d, which annualizes to roughly -186.2% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does INBX compare to its sector?

There are 148 other Healthcare tickers on Broken Stocks: 69 Red, 40 Amber, 39 Watch, with 25 showing recovering structural signals. Median sector decline is -34.5% — INBX's decline is deeper than the sector median.

Does INBX's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-14) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.